Could it be VEXAS?

Guerineau, Hippolyte; Kohn, Milena; Al Hamoud, Antoine; Sellier, Jacques; Osman, Jennifer; Cabannes-Hamy, Aurélie

Could it be VEXAS?

Guerineau, Hippolyte; Kohn, Milena; Al Hamoud, Antoine; Sellier, Jacques; Osman, Jennifer; Cabannes-Hamy, Aurélie.

Affiliation

Guerineau H; Department of Hematobiology, CH de Versailles, Le Chesnay, France. hguerineau@ght78sud.fr.
Kohn M; Department of Hematology and Oncology, CH de Versailles, Le Chesnay, France.
Al Hamoud A; Department of Hematology and Oncology, CH de Versailles, Le Chesnay, France.
Sellier J; Department of Radiology, CH de Versailles, Le Chesnay, France.
Osman J; Department of Hematobiology, CH de Versailles, Le Chesnay, France.
Cabannes-Hamy A; Department of Hematology and Oncology, CH de Versailles, Le Chesnay, France.

Ann Hematol ; 103(6): 2169-2171, 2024 Jun.

Article de En | MEDLINE | ID: mdl-38589717

ABSTRACT

ABSTRACT

We report the case of the youngest patient described with VEXAS syndrome associated with MDS-IB1, successfully treated with azacitidine-venetoclax and allogeneic stem cell transplant.

Sujet(s)
Mots clés

Allograft; Myelodysplasia; UBA1; Vexas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Azacitidine / Syndromes myélodysplasiques Limites: Humans / Male Langue: En Journal: Ann Hematol Sujet du journal: HEMATOLOGIA Année: 2024 Type de document: Article Pays d'affiliation: France Pays de publication: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google